Human CTLA-4 ELISA Kit (Colorimetric) NBP1-91268 from Novus Biologicals, a Bio-Techne Brand | Biocompare.com

Supplier Images

Human CTLA-4 ELISA Kit (Colorimetric)
Human CTLA-4 ELISA Kit (Colorimetric)

Human CTLA-4 ELISA Kit (Colorimetric)
Human CTLA-4 ELISA Kit (Colorimetric)

ELISA: Human CTLA-4 ELISA Kit (Colorimetric) [NBP1-91268] - CTLA-4 expression in human lung cancer cell lines determined by ELISA. ELISA image submitted by a verified customer review.
Human CTLA-4 ELISA Kit (Colorimetric)

ELISA: Human CTLA-4 ELISA Kit (Colorimetric) [NBP1-91268] - CTLA-4 expression in human lung cancer cell lines determined by ELISA. ELISA image submitted by a verified customer review.
Human CTLA-4 ELISA Kit (Colorimetric)

Be the first to write a review!

Citations:

Supplier Page from
Novus Biologicals, a Bio-Techne Brand for
Human CTLA-4 ELISA Kit (Colorimetric)

Product Specs
ItemHuman CTLA-4 ELISA Kit (Colorimetric)
CompanyNovus Biologicals, a Bio-Techne Brand
Price $629.00Supplier Page View Company Product Page
Catalog NumberNBP1-91268
Quantity96 Tests
ApplicationsELISA
ReactivityHuman
Detection Range0.16 - 10.0 ng/mL
Sample TypeCell culture supernatant, serum, plasma (EDTA, heparin), amniotic fluid
Sensitivity0.13 ng/mL
Detection TargetCTLA-4
StorageStorage of components varies. See protocol for specific instructions
NCBI Full Gene Namecytotoxic T-lymphocyte associated protein 4
NCBI Gene AliasesALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
Research AreaAdaptive Immunity, Autoimmune Diseases, Cancer, Immune System Diseases, Immunology, Neuroscience, Signal Transduction

Add to Compare List

Novus Biologicals, a Bio-Techne Brand

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

Company Profile

Website: https://www.novusbio.com

(1) hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allograftsEBioMedicineDecember 1, 2020Todorova D, Zhang Y, Chen Q, Liu J, He J, Fu X, Xu Y.

(2) TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes MellitusClinical immunology (Orlando, Fla.)June 1, 2020Lampropoulou IT, Stangou Μ, Sarafidis P, Gouliovaki A, Giamalis P, Tsouchnikas I, Didangelos T, Papagianni Α.

(3) ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung CancerMolecular pharmaceuticsMay 1, 2017Ehlerding EB, England CG, Majewski RL, Valdovinos HF, Jiang D, Liu G, McNeel DG, Nickles RJ, Cai W.

Be the First to Write a Review!